ProShare Advisors’s Soleno Therapeutics SLNO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $690K | Buy |
8,239
+2,700
| +49% | +$226K | ﹤0.01% | 951 |
|
|
2025
Q1 | $396K | Sell |
5,539
-1,667
| -23% | -$119K | ﹤0.01% | 1221 |
|
|
2024
Q4 | $324K | Buy |
7,206
+2,836
| +65% | +$127K | ﹤0.01% | 1573 |
|
|
2024
Q3 | $221K | Buy |
+4,370
| New | +$221K | ﹤0.01% | 1670 |
|
|
2021
Q2 | – | Sell |
-1,075
| Closed | -$20K | – | 2398 |
|
|
2021
Q1 | $20K | Buy |
1,075
+195
| +22% | +$3.63K | ﹤0.01% | 2257 |
|
|
2020
Q4 | $25K | Buy |
+880
| New | +$25K | ﹤0.01% | 2081 |
|